2.49
price up icon2.47%   0.06
pre-market  Vorhandelsmarkt:  2.62   0.13   +5.22%
loading

Aclaris Therapeutics Inc Aktie (ACRS) Neueste Nachrichten

pulisher
Feb 09, 2025

Equities Analysts Issue Forecasts for ACRS FY2029 Earnings - MarketBeat

Feb 09, 2025
pulisher
Feb 09, 2025

What is Leerink Partnrs' Forecast for ACRS FY2025 Earnings? - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Research Analysts Issue Forecasts for ACRS FY2029 Earnings - Armenian Reporter

Feb 08, 2025
pulisher
Feb 08, 2025

StockNews.com Downgrades Aclaris Therapeutics (NASDAQ:ACRS) to Sell - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Aclaris Therapeutics Inc (ACRS) Shares Decline Despite Market Challenges - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Aclaris Therapeutics Inc (ACRS) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

What is Leerink Partnrs’ Forecast for ACRS FY2025 Earnings? - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Analysts - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

Aclaris Therapeutics Inc [ACRS] Records 50-Day SMA of $2.98 - Knox Daily

Feb 06, 2025
pulisher
Feb 05, 2025

Aclaris Therapeutics forms new Scientific Advisory Board - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

The Aclaris Therapeutics Inc (ACRS) had a good session last reading, didn’t it? - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Aclaris Therapeutics Inc (ACRS)’s Market Momentum: Closing Strong at 2.40, Down -3.23 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Healthy Upside Potential: Aclaris Therapeutics Inc (ACRS) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Market Insight: Eterna Therapeutics Inc (ERNA)’s Notable Drop, Closing at 0.36 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Aclaris Therapeutics (NASDAQ:ACRS) Cut to Sell at StockNews.com - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Aclaris Therapeutics (NASDAQ:ACRS) Upgraded at Cantor Fitzgerald - Defense World

Feb 02, 2025
pulisher
Feb 01, 2025

Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts - MSN

Feb 01, 2025
pulisher
Feb 01, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Short Interest Up 12.7% in January - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

Aclaris Therapeutics forms new Scientific Advisory Board By Investing.com - Investing.com Canada

Jan 30, 2025
pulisher
Jan 30, 2025

Aclaris Therapeutics Appoints Marianne Mann and Zuzana Diamant to Scientific Advisory Board - citybiz

Jan 30, 2025
pulisher
Jan 25, 2025

Assenagon Asset Management S.A. Acquires 211,585 Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Shares Purchased by Assenagon Asset Management S.A. - MarketBeat

Jan 25, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Comments on ACRS FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Cantor Fitzgerald Weighs in on ACRS FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 18, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Short Interest Up 12.7% in December - MarketBeat

Jan 18, 2025
pulisher
Jan 16, 2025

Hair Treatment Drug Market Is Booming Worldwide | 3S Bio, Inc.,AbbVie,Aclaris Therapeutics, Inc.,Cipla, Inc. - openPR

Jan 16, 2025
pulisher
Jan 16, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives $11.00 Average Target Price from Brokerages - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Shares Sold by Jane Street Group LLC - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Reduces Holdings in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Aclaris Therapeutics Highlights Drug Progress and Financial Strength - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Jan 13, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Grows Stock Holdings in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

Jan 11, 2025
pulisher
Jan 08, 2025

Aclaris Therapeutics Awards Stock Options to Attract Top Talent - MSN

Jan 08, 2025
pulisher
Jan 06, 2025

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Jan 06, 2025
pulisher
Jan 06, 2025

Hair Loss Treatment Market Is Booming Worldwide 2024-2031 | Viviscal, Cipla Inc., Aclaris Therapeutics - openPR

Jan 06, 2025
pulisher
Jan 04, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Shares Sold by State Street Corp - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

Aclaris sells OLUMIANT royalties and milestones to OMERS life sciences - MSN

Jan 03, 2025
pulisher
Jan 03, 2025

HC Wainwright & Co. Upgrades Aclaris Therapeutics (ACRS) - MSN

Jan 03, 2025
pulisher
Jan 01, 2025

ACRS LOSS NOTICE: ROSEN, A LEADING FIRM, Announces Filing of Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the FirmACRS - AccessWire

Jan 01, 2025
diagnostics_research DGX
$162.64
price up icon 0.00%
diagnostics_research LH
$246.27
price down icon 0.59%
$172.82
price down icon 1.32%
diagnostics_research WAT
$409.50
price down icon 0.35%
diagnostics_research MTD
$1,390.00
price up icon 2.41%
diagnostics_research IQV
$208.14
price down icon 0.87%
Kapitalisierung:     |  Volumen (24h):